Library Subscription: Guest
Begell Digital Portal Begell Digital Library eBooks Journals References & Proceedings Research Collections
Critical Reviews™ in Eukaryotic Gene Expression
IF: 2.156 5-Year IF: 2.255 SJR: 0.649 SNIP: 0.599 CiteScore™: 3

ISSN Print: 1045-4403
ISSN Online: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.2013006917
pages 103-113

Combined Gene Expression and DNA Occupancy Profiling as a Strategy to Identify Therapeutic Target(s) in t(8;21) Acute Myeloid Leukemia

Miao-Chia Lo
Moores Cancer Center, University of California San Diego, La Jolla, California
Luke F. Peterson
Division of Hematology and Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan

ABSTRACT

Microarray technology has contributed valuable information to gene expression signatures of leukemia and other types of cancers and helped to identify biological markers and potential therapeutic targets for treating these diseases. Acute myeloid leukemia (AML) is often caused by aberrant fusion transcription factors resulting from chromosomal translocations, and the dysregulated genes detected by microarray include both direct and indirect targets of the oncogenic transcription factors. The ChIP-chip technology enables the identification of direct targets of a transcription factor based on its promoter occupancy and cellular context. Using AML1-ETO9a-induced AML as a cancer model and using a combined gene expression and promoter occupancy profiling approach, we recently identified CD45 as a direct down-regulated target of t(8;21) fusion proteins. This finding subsequently led us to discover the enhanced Janus activated kinase (JAK)/signal transducer and activator of transcription (STAT) signaling pathway, which is negatively regulated by CD45, in t(8;21) AML. This review summarizes the background of t(8;21) leukemia, structural features of the translocation fusion proteins, and the merits of combining gene discovery technologies for the identification of therapeutic targets in t(8;21) leukemia.


Articles with similar content:

Role of NF-κB in Tumorigenesis
Forum on Immunopathological Diseases and Therapeutics, Vol.4, 2013, issue 2
Gautam Sethi, Muthu K. Shanmugam, Alan P. Kumar, Benny K. H. Tan
The Effects of Nrf2 on Tumor Angiogenesis: A Review of the Possible Mechanisms of Action
Critical Reviews™ in Eukaryotic Gene Expression, Vol.22, 2012, issue 2
Wenguang Ye, Mingxin Zhang, Suna Zhou, Jun liang
Aberrant Regulation of Alternative Pre-mRNA Splicing in Hepatocellular Carcinoma
Critical Reviews™ in Eukaryotic Gene Expression, Vol.24, 2014, issue 2
Shuixiang Xie, Fan Zhu, Lijuan Liu, Chuanjie Zhang
Multiple-Scales Integrative Analysis of MicroRNAs Unveils Biomarkers and Key Regulatory Connections for Hepatocellular Carcinoma
Critical Reviews™ in Eukaryotic Gene Expression, Vol.29, 2019, issue 3
Xiaohong Xiang, Wanyan Deng, Keli Qian, Qian Li
The Transcription Regulator Kruppel-Like Factor 4 and Its Dual Roles of Oncogene in Glioblastoma and Tumor Suppressor in Neuroblastoma
Forum on Immunopathological Diseases and Therapeutics, Vol.7, 2016, issue 1-2
Swapan K. Ray